Original paper
IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: a case report
Abstract
Background Immune checkpoint inhibitors (ICIs) are the standard treatment for non-small cell lung cancer. The unique adverse events that can arise after treatment with ICIs are known as immune-related adverse events (irAE). As the number of cases under treatment with ICIs increases, new types of characteristics of irAE have emerged. This case report suggests that IgG4-related pleural disease could occur as an irAE. Case presentation A...
Paper Details
Title
IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: a case report
Published Date
Apr 25, 2020
Journal
Volume
20
Issue
1
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History